No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
155 |
4. Check minimum number of eventsNone |
155 |
5. Include endpointsNone |
155 |
6. Filter based on genotype QC (FinnGen only) |
155 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80
- Name in latin
- Deficientia selectiva immunoglobulini A
Similar endpoints
↥List of similar endpoints to
Selective deficiency of immunoglobulin A [IgA]y
based on the number of shared cases.
Similar with more cases:
- Immunodeficiency with predominantly antibody defects
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1030 | 548 | 479 |
| Only index persons | 873 | 467 | 406 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 23.14 | 26.92 | 18.74 |
| Only index persons | 27.90 | 32.01 | 23.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 155 | 94 | 61 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 39.16 | 37.72 | 41.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 146
- Matched controls
- 1459
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
175.6
131
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
30.3
28
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
23.6
22
*
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
22.5
21
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
22.5
21
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
22.5
21
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
21.4
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.0
18.6
89
348
J01MA14
ATC
moxifloxacin; systemic
10.4
18.2
37
46
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
15.9
15
*
ZX120
NOMESCO Finland
Intravenous
7.4
15.8
40
71
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
14.1
15.3
26
22
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
11.2
14.2
27
29
H02AB06
ATC
prednisolone; systemic
3.8
13.4
90
431
Z3231
NOMESCO Finland
Registered nurse
4.0
13.3
70
273
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.2
13.3
61
211
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.5
13.1
54
168
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
6.9
12.4
32
57
R50.9
ICD-10 Finland
Fever, unspecified
5.1
11.7
40
101
J47
ICD-10 Finland
Bronchiectasis
22.2
11.4
16
8
6BA02
NOMESCO Finland
NA
47.2
11.1
13
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
11.0
48
154
J01MA12
ATC
levofloxacin; systemic
4.5
10.6
41
117
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.5
10.2
31
68
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
9.7
38
109
K90.0
ICD-10 Finland
Coeliac disease
13.6
9.6
16
13
Z2221
NOMESCO Finland
Medical doctor
3.2
9.4
61
264
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
11.1
9.3
17
17
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
9.3
69
325
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.4
9.2
52
202
M05BA04
ATC
alendronic acid; oral
7.8
8.9
20
29
J01FA06
ATC
roxithromycin; oral
2.9
8.6
75
389
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
11.8
8.5
15
14
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.6
8.3
41
144
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.3
8.2
25
55
P01BA02
ATC
hydroxychloroquine; oral
5.7
7.8
22
44
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
4.8
7.8
26
63
Z3226
NOMESCO Finland
Physiotherapist
3.4
7.8
41
149
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.0
7.8
21
40
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
6.0
7.8
21
40
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
26.6
7.7
10
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.7
7.6
97
613
J45.9
ICD-10 Finland
Asthma, unspecified
3.3
7.5
41
154
J01FA09
ATC
clarithromycin; systemic
2.8
7.4
61
300
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
8.0
7.4
16
22
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
7.3
7
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.8
7.3
20
39
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.9
7.1
23
54
H02AB07
ATC
prednisone; oral
3.7
7.0
32
104
WX892
NOMESCO Finland
Monitored bed care
5.5
7.0
20
41
C03CA01
ATC
furosemide; systemic
3.4
7.0
35
123
TDM10
NOMESCO Finland
Puncture of maxillary antrum
10.1
6.9
13
14
R03BA05
ATC
fluticasone; inhalant
3.1
6.8
41
163
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.0
6.8
21
47
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.6
6.8
23
57
J01FA15
ATC
telithromycin; oral
4.1
6.8
26
73
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.5
6.7
23
58
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
6.6
46
203
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
6.1
6.5
17
31
R03AC02
ATC
salbutamol; inhalant
2.4
6.4
89
569
L04AA13
ATC
leflunomide; oral
9.9
6.4
12
13
J01MA02
ATC
ciprofloxacin; systemic
2.5
6.4
61
322
H04.10
ICD-10 Finland
Dry eye syndrome
4.4
6.3
22
56
J01FA01
ATC
erythromycin; systemic
3.3
6.3
34
124
R03DC03
ATC
montelukast; oral
3.0
6.3
38
151
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
6.3
6
*
J01DA06
ATC
[U] cefuroxime; systemic
3.2
6.2
34
126
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.4
6.2
90
584
J01AA02
ATC
doxycycline; systemic
2.6
6.2
112
814
R4110
NOMESCO Finland
Physiotherapy
2.7
6.1
48
225
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4062490)
26
12
25.83
35.57
1.3
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
47
93
6.82
24.44
1.6
1.2
u/ml
154.4
371.1
0.38
38
86
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
39
68
7.33
22.79
1.9
1.1
u/ml
100.5
—
—
12
0
(3007164) IgA [Mass/volume] in Serum or Plasma
90
338
4.96
22.07
2.8
1.4
g/l
1.0
2.3
5.48
23
208
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
13
16.52
21.43
1.6
1.5
e6/l
943.6
850.6
—
8
7
(3013115) Eosinophils [#/volume] in Blood
129
658
6.73
21.20
13.5
7.2
e9/l
0.2
0.2
0.09
124
589
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
7
42.15
20.56
1.8
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
126
641
6.16
20.45
13.5
6.9
e9/l
0.0
0.0
0.24
119
563
(3001604) Monocytes [#/volume] in Blood
126
642
6.15
20.38
13.5
6.9
e9/l
0.5
0.5
0.03
119
564
(3019198) Lymphocytes [#/volume] in Blood
127
662
6.08
19.67
13.3
6.8
e9/l
1.8
1.9
0.42
121
593
(42870588) Differential panel, method unspecified - Blood
95
403
4.51
19.12
12.7
7.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
21
5
48.21
17.79
3.4
1.4
u/ml
568.4
1023.0
—
21
5
(3013650) Neutrophils [#/volume] in Blood by Automated count
132
756
6.03
16.95
15.7
10.5
e9/l
3.9
3.9
0.08
124
657
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
98
513
3.48
12.77
11.0
8.5
mmol/l
1.2
1.2
0.24
84
443
(3024561) Albumin [Mass/volume] in Serum or Plasma
90
455
3.33
12.28
7.2
5.3
g/l
36.8
36.6
0.15
82
439
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
95
501
3.32
11.98
3.5
2.4
nmol/l
75.7
74.4
0.21
89
453
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
15
5
32.93
11.88
2.1
1.2
%
24.5
26.6
—
15
5
(3023419) Bacteria identified in Sputum by Culture
12
10
12.92
11.88
5.2
3.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
67
294
3.25
11.42
6.4
4.4
ph
7.4
7.4
0.54
17
54
(3006245) CD3-CD19+ cells/100 cells in Blood
15
6
27.44
11.37
2.1
1.7
%
13.7
7.5
—
15
6
(3032773) Endomysium IgG Ab [Titer] in Serum
16
22
7.99
11.21
1.6
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
5
30.52
10.93
1.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
14
5
30.52
10.93
1.0
1.0
%
94.0
81.6
—
14
5
(3037522) Nuclear Ab [Titer] in Serum
47
177
3.38
10.15
1.7
1.5
titre
301.5
537.3
0.78
13
37
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
70
4.46
9.90
2.9
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
168
3.37
9.82
2.3
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
58
255
3.04
9.58
8.0
4.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
9
0
+∞
9.47
1.2
0.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
41
150
3.36
9.19
2.3
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
67
325
2.87
9.19
13.0
8.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
32
100
3.77
9.10
3.3
3.6
%
1.9
1.6
1.18
27
95
(3023520) Reticulocytes [#/volume] in Blood
26
70
4.26
9.06
3.1
2.8
e9/l
70.7
70.7
0.00
21
58
(3004588) Protein electrophoresis panel - Serum or Plasma
22
52
4.77
9.00
2.5
4.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
29
86
3.92
8.87
5.0
6.4
%
0.4
0.4
—
6
19
(3021589) Normoblasts [#/volume] in Blood
99
596
2.83
8.85
19.5
9.5
e9/l
0.0
0.0
0.00
87
481
(3017181) Myelocytes/100 leukocytes in Blood
31
97
3.74
8.79
4.7
6.7
%
0.9
0.7
—
7
32
(36304419) Bacteria [Presence] in Urine
67
334
2.77
8.62
5.2
2.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
0
+∞
8.40
1.3
0.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
140
3.27
8.37
1.9
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
52
235
2.83
7.97
5.8
2.7
mosm/kgh2o
513.9
564.6
0.76
47
204
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
76
418
2.61
7.87
5.4
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
36
135
3.17
7.66
1.8
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
36
139
3.07
7.27
11.7
7.9
mmol/l
1.1
1.1
0.18
36
129
(3030467) Casts [#/volume] in Urine by Automated count
64
338
2.52
7.05
5.6
2.7
e6/l
0.2
0.4
0.98
49
249
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
32
5.08
6.85
2.2
3.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
67
368
2.45
6.72
5.5
2.8
e6/l
10.8
46.7
1.95
52
280
(3021440) Promyelocytes/100 leukocytes in Blood
27
92
3.34
6.66
5.2
6.9
%
0.0
0.1
—
6
27
(3018095) Leukocytes [#/volume] in Urine
75
440
2.37
6.42
5.8
3.4
e6/l
127.3
28.8
0.50
55
297
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
13
26
5.37
6.35
2.4
4.5
g/l
0.0
0.0
0.00
13
26
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
19
6.16
6.20
2.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
26
92
3.19
6.03
5.3
6.8
%
0.0
0.0
—
5
26
(3015377) Calcium [Moles/volume] in Serum or Plasma
66
378
2.30
5.85
2.8
3.3
mmol/l
2.3
2.3
0.07
59
334
(40760892) CBC W Ordered Manual Differential panel - Blood
58
316
2.33
5.77
5.9
5.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
41
193
2.53
5.60
2.7
2.5
e6/l
2.8
2.2
0.16
19
97
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
115
2.87
5.52
2.5
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
14
34
4.43
5.49
1.2
1.3
—
—
—
0
0
(3015736) pH of Urine
77
482
2.19
5.39
3.4
2.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
26
4.92
5.36
1.4
1.4
ug/g
387.4
327.5
—
7
13
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
35
4.30
5.29
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
31
4.49
5.20
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
31
4.49
5.20
1.7
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
200
2.43
5.16
2.7
2.3
e6/l
0.7
0.9
0.29
19
104
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
337
2.21
5.14
2.4
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
23
5.07
5.10
1.3
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
115
2.75
4.98
2.6
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
63
374
2.15
4.95
8.3
7.4
inr
1.0
1.1
2.38
18
122
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
66
399
2.14
4.95
2.4
1.8
pmol/l
87.7
97.1
0.96
37
200
(40768797) Stomach Pathology biopsy report
34
155
2.53
4.92
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
28
4.56
4.92
3.7
2.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
28
4.56
4.92
1.4
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
10
9.47
4.85
2.3
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
7
11.96
4.84
1.3
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
108
792
2.20
4.83
6.6
3.9
—
23.3
—
0
16
(40768443) Skin Pathology biopsy report
15
43
3.75
4.74
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
33
151
2.51
4.73
1.9
1.6
nmol/l
1160.1
1173.4
0.03
28
117
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
29
4.40
4.72
1.4
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
29
4.40
4.72
2.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
25
4.66
4.64
1.9
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
11
8.60
4.63
2.1
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
45
239
2.24
4.62
1.9
1.4
nmol/l
21.0
22.9
0.32
37
207
(3017143) Hepatitis C virus Ab [Presence] in Serum
41
211
2.28
4.53
2.1
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
35
3.96
4.47
1.2
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
78
2.96
4.46
5.9
4.6
mmol/l
1.0
1.3
0.11
16
60
(3037467) Urinalysis macro (dipstick) panel - Urine
113
863
2.14
4.29
7.4
3.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
57
3.23
4.27
2.4
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
81
2.84
4.18
8.0
8.7
mmol/l
22.8
25.9
5.13
21
81
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
10
8.36
4.11
4.5
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
49
282
2.08
4.05
2.1
2.1
mg/l
1.3
0.8
0.70
38
217
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
48
3.35
4.05
1.2
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
87
613
1.96
4.04
6.1
3.1
estimate
0.0
0.0
0.00
19
132
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
292
2.05
3.97
1.7
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
15
6.29
3.87
2.8
11.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
10
25
4.21
3.76
1.2
1.2
—
1.1
—
0
11
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
10
25
4.21
3.76
2.6
4.5
g/l
0.0
0.0
—
10
25
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
10
25
4.21
3.76
2.6
4.5
g/l
0.0
0.0
—
10
25
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
51
3.15
3.69
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
26
4.04
3.58
1.9
2.2
—
—
—
0
0
(3012544) pH of Venous blood
25
115
2.40
3.52
5.9
7.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
42
3.29
3.46
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
85
616
1.84
3.43
7.9
4.4
estimate
0.0
0.0
0.00
19
132
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
10
7.27
3.40
4.1
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
137
1169
2.48
3.39
20.8
10.8
ml/min/173m2
89.6
88.9
0.10
124
933
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
54
2.97
3.36
2.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
72
2.70
3.35
1.4
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
85
620
1.82
3.32
6.2
3.2
estimate
0.0
0.0
0.50
18
126
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
55
2.91
3.26
1.7
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
61
2.81
3.25
6.3
4.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
15
5.56
3.23
2.5
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
15
5.56
3.23
7.8
2.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
120
981
1.99
3.20
5.5
3.8
pmol/l
14.7
14.5
0.33
113
906
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
50
2.98
3.18
1.4
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
209
2.01
3.15
3.8
2.9
ug/g
249.7
101.5
1.30
30
166
(3002032) Base excess in Venous blood by calculation
24
114
2.31
3.15
6.1
7.1
mmol/l
0.8
2.2
0.75
17
87
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
217
2.00
3.14
1.3
1.3
iu/ml
10.4
27.0
—
9
72
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
57
373
1.84
3.14
5.1
3.4
ng/l
301.8
38.6
0.61
29
215
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
16
5.21
3.09
2.5
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
16
5.21
3.09
2.5
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
16
5.21
3.09
2.5
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
16
5.21
3.09
2.5
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
16
5.21
3.09
2.5
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
12
6.05
3.05
4.1
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
40
3.17
3.04
2.3
5.1
g/l
1.0
0.2
—
5
21
(3000991) Gas panel - Venous blood
22
104
2.30
2.91
7.4
9.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
49
312
1.83
2.91
7.0
3.5
estimate
0.0
0.0
0.50
18
132
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
47
2.93
2.89
2.4
3.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
31
3.38
2.82
6.8
4.5
%
61.7
55.4
—
10
31
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
31
3.38
2.82
6.7
3.7
e9/l
4.9
3.9
—
10
31
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
23
4.09
2.82
2.6
1.5
—
—
—
0
0
(3000492) Spirometry study
26
134
2.13
2.81
2.3
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
226
1.90
2.78
1.3
1.3
u/ml
1.6
6.0
1.04
20
95
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
6
8.56
2.77
1.4
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
6
8.56
2.77
1.4
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
6
8.56
2.77
1.4
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
115
2.17
2.68
3.1
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
56
2.65
2.61
1.1
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
20
4.16
2.60
1.5
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
42
264
1.81
2.57
3.7
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
7
7.33
2.56
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
49
324
1.75
2.53
4.4
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
42
266
1.79
2.51
3.0
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
51
342
1.73
2.50
4.3
3.1
mmol/l
8.2
8.5
0.16
41
296
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
16
4.53
2.50
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
21
3.96
2.50
1.4
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
65
469
1.66
2.43
6.7
3.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
8
6.41
2.39
1.4
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
8
6.41
2.39
1.4
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
8
6.41
2.39
1.4
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
8
6.41
2.39
1.4
2.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
17
4.26
2.39
1.1
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
17
4.26
2.39
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
24
128
2.04
2.38
1.8
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
47
2.68
2.33
2.3
4.2
%
92.0
96.7
0.42
12
47
(3044889) 12 lead EKG panel
101
821
1.66
2.32
4.3
3.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
13
4.75
2.29
2.8
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
18
4.02
2.28
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
29
3.23
2.26
3.4
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
9
5.70
2.23
1.4
1.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
9
5.70
2.23
1.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
124
2.00
2.21
1.3
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
24
3.46
2.21
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
43
285
1.70
2.17
3.4
3.1
umol/l
356.9
6505.8
1.55
38
260
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
14
4.41
2.17
1.2
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
14
4.41
2.17
2.8
1.1
—
—
—
0
0
(4010399)
18
89
2.16
2.16
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
52
365
1.64
2.11
3.1
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
31
3.02
2.11
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
51
357
1.64
2.09
1.9
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29
173
1.83
2.08
2.9
3.1
mmol/l
2.4
2.4
0.22
23
157
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
10
5.12
2.08
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
25
142
1.91
2.08
3.2
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
39
255
1.71
2.06
3.7
3.2
kg/l
1.0
1.0
—
5
30
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
38
2.74
2.05
8.9
23.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
129
1.92
1.99
1.3
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
45
2.55
1.98
1.8
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
11
45
2.55
1.98
1.5
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
11
4.66
1.95
1.4
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.66
1.95
1.4
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.66
1.95
1.4
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
16
3.86
1.95
1.2
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
81
2.09
1.82
1.8
1.1
—
—
—
0
0
(3019225) pH of Specimen
17
89
2.02
1.78
8.6
5.1
—
—
—
0
0
(3002256) Pathology report gross observation
25
151
1.78
1.73
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
13
3.94
1.73
1.2
3.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
13
3.94
1.73
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
13
3.94
1.73
1.8
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
38
528
0.63
1.69
4.2
2.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
61
465
1.51
1.68
2.4
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
43
2.42
1.64
3.1
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
14
3.65
1.63
1.4
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
101
1.88
1.57
5.4
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
46
335
1.53
1.55
1.4
1.6
mmol/l
1.5
1.4
0.41
37
287
(3041096) Erythrocytes [Presence] in Urine by Automated
49
362
1.52
1.55
7.4
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
117
1031
1.55
1.53
4.9
3.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
21
2.93
1.52
2.0
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
74
1.98
1.44
3.6
3.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
53
2.16
1.42
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
23
2.67
1.38
2.7
2.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
47
2.21
1.37
4.0
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
158
0.48
1.34
1.3
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
24
2.56
1.31
1.3
2.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
92
1.82
1.31
1.4
1.2
—
27.2
—
0
7
(3028271) Lactate [Moles/volume] in Capillary blood
5
18
2.83
1.29
2.8
2.6
mmol/l
1.0
1.7
—
5
18
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
18
2.83
1.29
1.4
2.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
38
276
1.50
1.29
4.1
3.1
mg/l
118.3
63.1
0.30
23
180
(3044290) Cell count panel - Cerebral spinal fluid
6
25
2.45
1.25
1.7
2.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
19
2.68
1.22
3.0
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
20
127
1.66
1.18
8.1
8.7
mmol/l
105.7
104.0
1.00
20
122
(3014007) Fractional oxyhemoglobin in Arterial blood
11
58
1.97
1.15
8.9
10.3
%
92.6
94.2
0.29
11
58
(3035637) Corticotropin [Mass/volume] in Plasma
5
21
2.43
1.10
1.2
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
21
2.43
1.10
6.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
21
2.43
1.10
2.0
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
39
294
1.44
1.09
6.3
3.9
mg/mmol
29.8
10.6
0.37
27
185
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
68
566
1.36
1.07
4.6
4.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
75
1.80
1.06
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
47
1.97
1.04
1.2
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
22
2.31
1.04
4.2
3.1
kpa
9.1
9.4
—
5
22
(3013290) Carbon dioxide [Partial pressure] in Blood
5
22
2.31
1.04
4.0
3.1
kpa
4.9
5.2
—
5
22
(42529406) Shigella sp [Presence] in Stool by Culture
9
48
1.93
1.02
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
23
2.21
0.99
2.2
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
23
2.21
0.99
1.6
10.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
30
0.00
0.98
0.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
51
1.81
0.96
13.6
4.7
%
55.5
55.9
—
9
51
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
27
199
1.43
0.86
4.0
3.4
ng/l
229.4
222.6
0.01
17
129
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
45
1.82
0.85
1.3
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
31
1.97
0.85
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
48
1.70
0.80
6.9
3.4
—
—
—
0
0
(4094501)
6
33
1.85
0.80
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
67
1.69
0.77
6.9
2.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
193
0.64
0.75
1.1
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
55
1.67
0.75
2.2
6.5
%
2.0
1.6
—
9
55
(40761536) Microorganisms panel - Urine sediment
16
110
1.51
0.72
11.7
3.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
11
69
1.64
0.70
1.9
1.6
mu/l
287.2
291.7
0.04
11
60
(3008898) HLA-B27 [Presence]
11
69
1.64
0.70
1.0
1.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
10
61
1.68
0.70
7.1
7.5
g/l
115.6
128.4
—
10
61
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
27
1.88
0.69
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
70
1.62
0.67
4.4
2.5
—
—
—
0
0
(3010421) pH of Blood
5
28
1.81
0.66
5.4
2.9
ph
7.4
7.4
—
5
22
(3002523) Influenza virus A Ag [Presence] in Specimen
5
29
1.75
0.64
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
29
1.75
0.64
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
135
1287
1.38
0.63
26.9
12.2
%
39.8
40.8
1.13
110
1061
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
20
0.00
0.61
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
22
0.00
0.60
0.0
2.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
22
0.00
0.60
0.0
1.3
—
7.7
—
0
15
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
33
269
1.29
0.58
3.4
3.7
ug/l
1.3
1.6
1.08
33
244
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
36
1.69
0.57
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
62
1.48
0.54
7.8
3.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
62
1.48
0.54
1.4
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
93
1.43
0.50
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
46
1.55
0.49
6.0
3.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
47
1.51
0.48
1.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
86
1.43
0.46
4.1
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
222
1.26
0.45
1.9
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
56
1.45
0.43
5.1
12.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
132
1270
1.27
0.43
5.0
4.1
mmol/l
2.7
2.8
0.88
126
1193
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
114
0.69
0.38
1.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
92
1.33
0.33
4.1
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
93
1.31
0.31
2.4
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
93
1.31
0.31
4.3
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
93
1.31
0.31
4.1
2.3
—
—
—
0
0
(4035726)
13
103
1.29
0.29
1.5
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
103
1.29
0.29
1.4
1.2
iu/ml
36.0
123.7
—
7
38
(3013512) EKG study
32
283
1.16
0.27
6.8
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
143
1401
1.27
0.27
24.6
10.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
24
208
1.18
0.26
1.5
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
99
949
1.12
0.24
4.3
3.2
u/l
41.0
40.2
0.03
94
913
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
123
1194
1.15
0.24
4.6
3.7
mmol/l
5.9
5.8
0.52
116
1116
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
88
1.27
0.23
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
5
41
1.23
0.22
5.4
7.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
42
1.20
0.21
1.4
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.6
—
51.6
—
0
11
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
50
1.21
0.20
5.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
37
402
0.90
0.19
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
24
214
1.14
0.19
3.3
3.9
%
25.2
23.0
—
9
81
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
158
1.16
0.17
2.8
2.6
ug/l
0.6
0.7
0.17
12
93
(3050129) First trimester maternal screen panel - Serum or Plasma
6
75
0.79
0.16
1.2
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
128
1256
1.11
0.14
4.7
3.8
mmol/l
1.4
1.4
0.47
122
1177
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
252
1.09
0.10
3.1
2.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
48
1.04
0.09
13.4
5.3
mmol/l
23.0
24.5
—
5
48
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
245
0.93
0.07
2.0
1.5
—
—
—
0
0
(1002224) Polysomnography panel
8
74
1.09
0.07
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
108
1096
0.95
0.07
7.3
4.8
mmol/mol
39.4
38.7
0.27
103
1041
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
228
1.06
0.05
3.3
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
121
1200
1.04
0.03
4.5
3.5
mmol/l
1.3
1.3
0.21
115
1121
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
114
0.96
0.00
12.9
6.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
9.8
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
53
0.94
0.00
1.4
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
0.9
—
0
9
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
213.8
—
0
6
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
150
1.00
0.00
1.3
1.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
14.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
82
0.97
0.00
1.6
1.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
-0.00
0.0
10.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
-0.00
0.0
3.4
—
57.0
—
0
7
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_DEF_IIGA and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have D3_DEF_IIGA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: D3_DEF_IIGA – Selective deficiency of immunoglobulin A [IgA]y
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data